Genelux (GNLX) Accumulated Depreciation (2022 - 2026)
Genelux's (GNLX) quarterly Accumulated Depreciation came in at $3.9 million in Q1 2026, little changed quarter-over-quarter from $3.9 million in Q4 2025.
Genelux (GNLX) Accumulated Depreciation (2022 - 2026) Analysis & Trends
Genelux's Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Accumulated Depreciation changed N/A year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.9 million, up 6.6% from the prior year.
- Accumulated Depreciation steadied at $3.9 million in Q1 2026 per GNLX's latest filing, from $3.9 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $3.9 million in Q1 2026 and bottomed at $2.9 million in Q4 2022.
- The 5-year median for Accumulated Depreciation is $3.7 million (2024), against an average of $3.6 million.
- Across the five-year window, Accumulated Depreciation advanced 16.92% in 2023 and increased 6.58% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $2.9 million in 2022, then climbed by 16.92% to $3.4 million in 2023, then climbed by 6.81% to $3.7 million in 2024, then rose by 6.6% to $3.9 million in 2025, then rose by 0.25% to $3.9 million in 2026.
- Per Business Quant, the three latest GNLX Accumulated Depreciation figures stand at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.93 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 3.81 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 3.63 Mn |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 2.95 Mn |